| Active substance | avalglucosidase alfa |
| Holder | Sanofi Belgium |
| Status | Closed |
| Indication | treatment of adult Pompe disease patients who have participated and exit the clinical studies COMET (EFC14028) or NEO-EXT (LTS13769) |
| Public documents | Approbation |
| Information for the patient | |
| Informed consent | |
| Last update | 05/10/2023 |